Skip to main content
. 2016 Oct 27;7(48):79736–79746. doi: 10.18632/oncotarget.12945

Figure 1. Expression levels of GPC5 in lung adenocarcinoma (LAC) and its clinical significance.

Figure 1

A. GPC5 mRNA expression in the TCGA LAC RNAseq dataset (normal n=57 vs tumor n=57, Fisher's t-test, p < 0.001). B and C. GPC5 down-regulated is associated with greater pTNM stage (p = 0.019) and N stage (p = 0.0093) (normal vs. tumor).